Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Atropine and neosynephrine effectively prevent floppy iris syndrome during cataract surgery.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

FFA and FAPD might be related or stages of the same disease.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A girl with a rare skin condition improved after one month of treatment with acitretin.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Oral tofacitinib effectively treats alopecia areata long-term with manageable side effects.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

Amlodipine impairs fertility in male rats by affecting sperm and testicular structure.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Tofacitinib helped regrow hair in most patients with severe hair loss.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

A 2-year-old boy had no hair and unusual organ placement, and it's unclear if it's genetic or coincidental.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Certain medications and conditions increase the risk of intraoperative floppy-iris syndrome.

Fibrosing alopecia in a pattern distribution is a type of hair loss that may often be overlooked, especially in men.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

A unique type of hair loss mimics another condition but has minimal inflammation and specific immune cells present.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Thyroid dysfunction can cause heart issues, and bedside ultrasound helps diagnose cardiac arrest causes.